| Englischer Name | Forschungscode | Forschungsphase | Firma | Indikationen | Klinische Studie |
|---|---|---|---|---|---|
| Pegfilgrastim biosimilar (Reliance Life Sciences) | R-TPR-029 | Phase 3 Clinical | Reliance Life Sciences | Neutropenia | Details |
| Filgrastim biosimilar (Bio-Ker) | BK-0023 | Phase 3 Clinical | Bio-Ker Srl | Neutropenia | Details |
| Filgrastim biosimilar (Virchow Group) | Neutrogen | Phase 3 Clinical | Virchow Group | Neutropenia | Details |
| Pegfilgrastim biosimilar (Kexing Biopharmaceutical) | PEG-G-CSF | Phase 3 Clinical | Shandong Kexing Bio-Products Co Ltd | Breast Neoplasms; Chemotherapy-Induced Febrile Neutropenia | Details |
| Long-acting Reconbinant human G-CSF(kexing) | GB-K02 | Phase 3 Clinical | Shandong Kexing Bio-Products Co Ltd | Neutropenia | Details |
| Filgrastim biosimilar(Blau Farmaceutica) | Phase 3 Clinical | Blau Farmaceutica Sa | Neutropenia | Details | |
| Pegylated human granulocyte colony stimulating factor (Sinovac Biotech) | Phase 3 Clinical | Shandong Kexing Bio-Products Co Ltd | Febrile Neutropenia | Details | |
| Anumigilimab | CSL-324; CSL324 G-CSFR; CSL-324-G-CSFR | Phase 2 Clinical | MuriGen Therapeutics, Zenyth Therapeutics Ltd | Anemia, Sickle Cell; Community Acquired Pneumonia; Coronavirus Disease 2019 (COVID-19); Hidradenitis Suppurativa; Palmoplantar pustulosis; Respiratory Distress Syndrome, Adult | Details |
| Pegfilgrastim ANF | PEG-G-CSF-ANF | Phase 2 Clinical | Prolong Pharmaceuticals Llc | Neutropenia | Details |
| GM-CSF / IL3 fusion protein | Phase 2 Clinical | Beijing Igus Medical Technology Development Co Ltd, Shanghai Zhao'An Medical Technology Co Ltd | Neuroblastoma | Details | |
| Recombinant Human Granulocyte Colony-Stimulating Factor(Children's Hospital of Soochow University) | Phase 2 Clinical | Children's Hospital of Soochow University | Leukemia, Myeloid, Acute | Details | |
| GPC-201 | GPC-201 | Phase 2 Clinical | GPCR Therapeutics USA Inc | Hematopoietic stem cell transplantation (HSCT) | Details |
| JZB-27 | JZB-27 | Phase 2 Clinical | Hunan Jingfeng Pharmaceutical Co Ltd, Shanghai Jingze Biotechnology Co Ltd | Neutropenia | Details |
| Albumin-granulocyte colony stimulating factor (Beijing BioFortune/Tianjin SinoBiotech) | SFR-9314; rHSA/GCSF | Phase 2 Clinical | Beijing Meifuyuan Biomedical Technology Co Ltd, Tianjin Puying Biotechnology Co Ltd | Agranulocytosis; Chemotherapy-Induced Febrile Neutropenia; Neutropenia | Details |
| Filgrastim biosimilar (Biogenomics) | Phase 1 Clinical | Biogenomics | Neutropenia | Details | |
| PEGylated G-CSF | BBT-015 | Phase 1 Clinical | Bolder Biotechnology | Acute Radiation Syndrome; Neutropenia | Details |
| Pegfilgrastim biosimilar (Bio-Ker) | Phase 1 Clinical | Bio-Ker Srl | Neutropenia | Details | |
| Pegfilgrastim biosimilar (Jiangsu Aosaikang Pharmaceutical) | Phase 1 Clinical | Jiangsu Aosaikang Pharmaceutical Co Ltd | Solid tumours | Details | |
| Pegylated recombinant human granulocyte colony stimulating factor (Jiangnan University) | Phase 1 Clinical | Jiangnan University | Multiple Myeloma | Details | |
| Pegfilgrastim biosimilar (Tanvex Biopharma) | TX-04 | Phase 1 Clinical | Tanvex BioPharma Inc | Details | |
| Granulocyte colony-stimulating factor(Kura Oncology Inc) | Phase 1 Clinical | Kura Oncology Inc | Hematologic Neoplasms; Leukemia; Leukemia, Myeloid; Leukemia, Myeloid, Acute; Neoplasms | Details | |
| Recombinant human granulocyte-stimulating factor(Zhongnan Hospital) | Phase 1 Clinical | Zhongnan Hospital Of Wuhan University | Hematologic Neoplasms | Details | |
| Polyethylene glycolized recombinant human granulocyte-stimulating factor(Zhongnan Hospital) | Phase 1 Clinical | Zhongnan Hospital Of Wuhan University | Hematologic Neoplasms | Details | |
| Filgrastim biosimilar (MenoGenix) | MNGX-100 | Phase 1 Clinical | Menogenix Inc | Menopausal symptoms | Details |
| Pegfilgrastim biosimilar (Megalabs) | Phase 1 Clinical | Megalabs | Neutropenia | Details | |
| Pegfilgrastim biosimilar (Affiliated Hospital of North Sichuan Medical College) | Clinical | Affiliated Hospital Of North Sichuan Medical College | Neutropenia | Details | |
| BSC-1020 | BSC-1020 | Clinical | Biosimilar Solutions Inc | Neoplasms | Details |
| BSC-0826 | BSC-0826 | Clinical | Biosimilar Solutions Inc | Neutropenia; Radiation Injuries | Details |
| Pegfilgrastim biosimilar (Accord Healthcare) | Clinical | Accord Healthcare | Febrile Neutropenia; Neutropenia | Details |
| Englischer Name | Forschungscode | Forschungsphase | Firma | Frühestes Markenname | Frühestes Genehmigungsland | Früheste Indikation | Früheste Genehmigungsgesellschaft | Früheste Genehmigungsdatum | Indikationen | Klinische Studie |
|---|---|---|---|---|---|---|---|---|---|---|
| Pegfilgrastim | R-1471; SD-01; SD/01; KRN-125 | Approved | Amgen Inc, Kyowa Hakko Kirin Co Ltd | Ristempa, Neulasta, G-Lasta, Neulastim | United States | Neutropenia | Amgen Inc | 2002-01-31 | Adenocarcinoma, Clear Cell; Breast Neoplasms; Carcinoma; Carcinoma, Adenosquamous; Carcinoma, Endometrioid; Diabetes Mellitus, Type 1; Endometrial Neoplasms; Esophageal Neoplasms; Head and Neck Neoplasms; Hematopoietic stem cell transplantation (HSCT); Leukemia, Myeloid, Acute; Lung Neoplasms; Lymphoma; Lymphoma, Non-Hodgkin; Neutropenia; Ovarian Neoplasms; Pancreatic Neoplasms; Prostatic Neoplasms; Sarcoma; Skin Melanoma; Stomach Neoplasms; Urinary Bladder Neoplasms | Details |
| Empegfilgrastim | BCD-017 | Approved | BIOCAD JSC | Extimia | Neutropenia | Details | ||||
| Pegfilgrastim biosimilar (Coherus BioSciences) | CHS-1701 | Approved | Coherus Biosciences Inc | Udenyca, UDENYCA | United States | Febrile Neutropenia | Coherus Biosciences Inc | 2018-09-21 | Acute Radiation Syndrome; Febrile Neutropenia; Neutropenia | Details |
| Filgrastim biosimilar (Institute of Medical Biology Chinese Academy of Medical Sciences) | Approved | Institute Of Medical Biology, Chinese Academy Of Medical Sciences | 吉洛因 | Mainland China | Myelodysplastic Syndromes; Leukopenia | Institute Of Medical Biology, Chinese Academy Of Medical Sciences | 2001-01-01 | Leukopenia; Myelodysplastic Syndromes | Details | |
| Pegfilgrastim biosimilar (Hospira) | HSP-130 | Approved | Hospira, Pfizer Inc | Nyvepria | United States | Febrile Neutropenia | Hospira Inc | 2020-06-10 | Febrile Neutropenia; Lymphoma, AIDS-Related; Lymphoma, Large B-Cell, Diffuse; Neutropenia | Details |
| Nartograstim | KW-2228; PE-2601; ND-28 | Approved | Kyowa Hakko Kirin Co Ltd | Neu-up | Japan | Neutropenia | Kyowa Hakko Kirin Co Ltd | 1994-04-01 | Neutropenia | Details |
| Pegfilgrastim biosimilar (Juta Pharma) | Approved | Juta Pharma | Grasustek | EU | Neutropenia | Juta Pharma Gmbh | 2019-04-26 | Neutropenia | Details | |
| Filgrastim biosimilar (Nanogen) | Approved | Nanogen Biopharmaceutical Co | Ficocyte | Vietnam | Neutropenia | Nanogen Biopharmaceutical Co | 2014-01-01 | Neutropenia | Details | |
| Filgrastim biosimilar (Blau Pharmaceuticals) | Approved | Blau Pharmaceuticals | Brazil | Neutropenia | Blau Pharmaceuticals | 2012-10-01 | Neutropenia | Details | ||
| Filgrastim biosimilar (PanPharmaceuticals) | Approved | Harvest Moon | India | Febrile Neutropenia | null | 2012-01-01 | Febrile Neutropenia | Details | ||
| Filgrastim biosimilar (Biosidus) | Approved | Biosidus | Neutromax, Granulostim | Neutropenia | Details | |||||
| Filgrastim biosimilar (Biocon) | Approved | Biocon Biopharmaceuticals | Nufil | India | Neutropenia | null | 2008-01-01 | Neutropenia | Details | |
| Pegfilgrastim biosimilar (Beijing SL Pharmaceutical) | Approved | Beijing Sl Pharmaceutical Co Ltd | Mainland China | Neutropenia | Beijing Sl Pharmaceutical Co Ltd | 2023-09-19 | Neutropenia | Details | ||
| Filgrastim biosimilar (Unilab) | Approved | Unilab | Neocyte | Neutropenia | Details | |||||
| Filgrastim biosimilar (GeneScience Pharmaceuticals) | Approved | Changchun GeneScience Pharmaceuticals Co Ltd | Scimax, 金磊赛强 | Mainland China | Neutropenia | Changchun GeneScience Pharmaceuticals Co Ltd | 1998-01-01 | Neutropenia | Details | |
| Pegfilgrastim biosimilar (Zydus Cadila) | Approved | Zydus Cadila | India | Neutropenia | Zydus Cadila | 2014-01-01 | Neutropenia | Details | ||
| Filgrastim biosimilar (Veropharm) | Approved | Abbott Laboratories | Mielastra | Neutropenia | Details | |||||
| Filgrastim | rhGCSF (Amgen/Kyowa Hakko Kirin); r-metHuG-CSF; REC-G-CSF; KRN-8601 | Approved | Amgen Inc, Kyowa Hakko Kirin Co Ltd | Granulokine, Gran, Nugraf, Neupogen, 惠尔血, 优保津, 吉赛欣 | United States | Neutropenia | Amgen Inc | 1991-02-20 | Alzheimer Disease; Anemia, Aplastic; Anemia, Diamond-Blackfan; Breast Neoplasms; Cardiomyopathy, Dilated; Colorectal Neoplasms; Crohn Disease; Diabetic Foot; Dyskeratosis Congenita; Fanconi Anemia; Fever; Graft vs Host Disease; Hematologic Neoplasms; HIV Infections; Hot Flashes; Ischemia; Ischemic Stroke; Leg Ulcer; Leukemia; Leukemia, Myelogenous, Chronic; Leukemia, Myeloid, Acute; Leukemia, Myeloid, Chronic-Phase; Leukemia, Myelomonocytic, Juvenile; Liver Cirrhosis; Lymphoma; Malnutrition; Menopausal symptoms; Multiple Myeloma; Musculoskeletal Diseases; Myelodysplastic Syndromes; Myeloproliferative Disorders; Neuroblastoma; Neutropenia; Pancreatic Neoplasms; Pancytopenia; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Primary Myelofibrosis; Shwachman-Diamond Syndrome; Sickle Cell Trait; Skin Melanoma; Solid tumours; Thrombocytopenia; Uveal melanoma | Details |
| Filgrastim biosimilar (Apotex/Intas) | Approved | Apotex, Intas Biopharmaceuticals | Grastofil, SciLocyte, Neukine, Accofil | India | Neutropenia | null | 2004-01-01 | Febrile Neutropenia; Neutropenia | Details | |
| Pegfilgrastim biosimilar (Harvest Moon Pharmaceuticals/PanPharmaceuticals) | Approved | Harvest Moon | India | Neutropenia | null | 2012-01-01 | Neutropenia | Details | ||
| Filgrastim biosimilar (Pharmstandard/Masterclone/CJSC Generium) | Approved | Cjsc Generium, Masterclone, Pharmstandard | Neipomax, Neupomax | Neutropenia | null | 2008-01-01 | Neutropenia | Details | ||
| Pegfilgrastim biosimilar (Intas Biopharmaceuticals) | INTP-5 | Approved | Apotex, Intas Biopharmaceuticals | Pegasta, Neupeg, Lapelga, Pelgraz | EU | Neutropenia | Accord Healthcare Slu | 2018-09-21 | Febrile Neutropenia; Neutropenia | Details |
| Filgrastim biosimilar (PT Kalbe) | Approved | Kalbe Farma | India | Neutropenia | Kalbe Farma | 2012-08-01 | Neutropenia | Details | ||
| Filgrastim biosimilar (Claris Lifesciences) | Approved | Claris Lifesciences Ltd | Fegrast | India | Neutropenia | Claris Lifesciences Ltd | 2012-01-01 | Neutropenia | Details | |
| Efbemalenograstim alfa | F-627 | Approved | Evive (Shanghai) Corp Ltd | 亿立舒, Ryzneuta, Bineuta | Mainland China | Neutropenia | Evive Biopharmaceutical (Beijing) Co Ltd | 2023-05-06 | Breast Neoplasms; Chemotherapy-Induced Febrile Neutropenia; Febrile Neutropenia; Neutropenia | Details |
| Recombinant human granulocyte colony-stimulating factor (Shandong Kexing Bioproducts Co Ltd) | Approved | Shandong Kexing Bio-Products Co Ltd | 白特喜 | Mainland China | Neutropenia | Shandong Kexing Bio-Products Co Ltd | 2001-01-01 | Neutropenia | Details | |
| Filgrastim biosimilar (Apexcela) | SBS-6002; Leuco-Plus-300 | Approved | Apexcela | Neutropenia | Details | |||||
| Recombinant human granulocyte colony-stimulating Factor (Shenzhen Xinpeng Bio-tech) | Approved | Shenzhen Sinobioway Xinpeng Biomedicine Co Ltd | 瑞血新 | Mainland China | Neutropenia | Shenzhen Sinobioway Xinpeng Biomedicine Co Ltd | 1999-01-01 | Neutropenia | Details | |
| Filgrastim biosimilar (CJ Corp) | Approved | HK inno.N Corporation | Neutropenia | Details | ||||||
| Filgrastim biosimilar (Xiamen Amoytop Biotech) | Approved | Xiamen Amoytop Biotech Co Ltd | 特尔津, Topneuter | Mainland China | Neutropenia | Xiamen Amoytop Biotech Co Ltd | 1999-01-01 | Neutropenia | Details | |
| Filgrastim biosimilar (Eurofarma) | Approved | Eurofarma | Granulen | Brazil | Neutropenia | Eurofarma | 2012-01-01 | Neutropenia | Details | |
| Filgrastim biosimilar (Sedico) | Approved | Sedico | Neutropenia | Details | ||||||
| Filgrastim biosimilar (Zenotech Laboratories) | Approved | Zenotech Laboratories | Neoplasms; Neutropenia | Zenotech Laboratories | 2006-03-01 | Neoplasms; Neutropenia | Details | |||
| Filgrastim biosimilar (Lupin) | Approved | Lupin Ltd | Lupifil | India | Neutropenia | Lupin Ltd | 2016-01-01 | Neutropenia | Details | |
| Filgrastim biosimilar (Beijing SL Pharmaceutical) | Approved | Beijing Sl Pharmaceutical Co Ltd | 立生素, Li Sheng Su | Mainland China | Neutropenia | Beijing Sl Pharmaceutical Co Ltd | 1998-01-01 | Neutropenia | Details | |
| Pegfilgrastim biosimilar (Nanogen Biopharmaceutical) | Approved | Nanogen Biopharmaceutical Co | Neutropenia | Details | ||||||
| Filgrastim biosimilar (Biolotus Biotech) | Approved | Biolotus | Kymun-CSF | Brazil | Neutropenia | Biolotus | 2016-06-01 | Neutropenia | Details | |
| Filgrastim biosimilar (Fresenius Kabi Oncology) | Approved | Fresenius Kabi Ag | India | Neutropenia | Fresenius Kabi Ag | 2012-08-01 | Neutropenia | Details | ||
| Tbo-filgrastim | TKN-732; XM-02 | Approved | Teva | Tevagrastim, Biograstim, Granix | United States | Neutropenia | Sicor Biotech Uab | 2008-09-15 | Hematopoietic stem cell transplantation (HSCT); Neutropenia | Details |
| Filgrastim biosimilar (Laboratorios AC Farma) | Approved | Laboratorios Ac Farma | FGM-Factor | Peru | Neutropenia | Laboratorios Ac Farma | 2012-01-01 | Neutropenia | Details | |
| Filgrastim biosimilar(Pooyesh Darou Pharmaceuticals) | G-CSF | Approved | Pooyesh Darou | PD-grastim | Febrile Neutropenia; Neutropenia | Details | ||||
| Filgrastim biosimilar (Chandra Bhagat Pharma) | Approved | Chandra Bhagat Pharma(Cbc) | Filgen | India | Neoplasms | Chandra Bhagat Pharma(Cbc) | 2012-08-01 | Neoplasms | Details | |
| Filgrastim biosimilar (Zydus Cadila) | Approved | Zydus Cadila | India | Neutropenia | Zydus Cadila | 2014-01-01 | Neutropenia | Details | ||
| Filgrastim biosimilar (AqVida) | Approved | Aqvida Gmbh | Leucita | Russian Federation | Neutropenia | Aqvida Gmbh | 2008-05-01 | Neutropenia | Details | |
| Filgrastim biosimilar (Incepta Pharmaceuticals) | Approved | Incepta Pharmaceuticals Ltd | Neutropenia | Details | ||||||
| Pegfilgrastim biosimilar (AryaTinaGene) | Approved | Aryatinagene Biopharmaceuticals | Tinapeg | Febrile Neutropenia | Details | |||||
| Recombinant human granulocyte colony-stimulating factor (Shanghai Sunway Biotech) | Approved | Shanghai Sunway Bio Co Ltd | 赛格力, SunGran | Mainland China | Neutropenia | Shanghai Sunway Bio Co Ltd | 1998-01-01 | Neutropenia | Details | |
| Filgrastim biosimilar (Laboratorio Varifarma) | Approved | Laboratorio Varifarma | Neutrofil | Neutropenia | Details | |||||
| Recombinant human granulocyte colony-stimulating factor (Harbin Pharmaceutical Group Bioengineering) | Approved | Harbin Pharmaceutical Group Holding Co Ltd | 里亚金, Li Ya Jin | Mainland China | Neutropenia | Harbin Pharmaceutical Group Holding Co Ltd | 2000-01-01 | Neutropenia | Details | |
| Eflapegrastim | LAPS-GCSF; HNK-460; SPI-2012; HM-10460A | Approved | Hanmi Pharmaceutical Co Ltd | ROLVEDON, Rolontis, Rolvedon, ROLONTIS | South Korea | Neutropenia | Hanmi Pharmaceutical Co Ltd | 2021-03-18 | Breast Neoplasms; Febrile Neutropenia; Lymphoma; Neutropenia; Solid tumours | Details |
| Recombinant Human Granulocyte Colony-stimulating Factor (Wuzhong Group) | Approved | Suzhou Pharmaceutical Factory | 洁欣, Jiexin | Mainland China | Neutropenia | Suzhou Pharmaceutical Factory | 1999-01-01 | Neutropenia | Details | |
| Filgrastim biosimilar (Chalver Laboratorios) | Approved | Chalver Laboratorios | Leucosos | Colombia | Neutropenia | Chalver Laboratorios | 2012-01-01 | Neutropenia | Details | |
| Filgrastim biosimilar (Siam Bioscience) | Approved | Siam Bioscience | Neutropenia | Details | ||||||
| Filgrastim biosimilar (Reliance Life Sciences) | Approved | Reliance Life Sciences | ReliGrast | India | Neutropenia | Reliance Life Sciences | 2008-01-01 | Neutropenia | Details | |
| Filgrastim biosimilar (Tanvex BioPharma) | TX-01 | Approved | Tanvex BioPharma Inc | NYPOZI | Canada | Febrile Neutropenia | Tanvex BioPharma Inc | 2021-10-17 | Chemotherapy-Induced Febrile Neutropenia; Febrile Neutropenia; Hematopoietic stem cell transplantation (HSCT); Neutropenia | Details |
| Recombinant human granulocyte stimulating factor (CSPC Pharma) | Approved | CSPC Pharmaceutical Group Ltd | 津恤力, GeneLeukim | Mainland China | Neutropenia | Cspc Baike (Shandong) Biopharmaceutical Co Ltd | 2000-01-01 | Neutropenia | Details | |
| Filgrastim biosimilar (Dong-A) | DA-3030 | Approved | Dong-A Pharmaceutical Co Ltd | Leukostim | South Korea | Neutropenia | Dong-A Pharmaceutical Co Ltd | 1999-01-01 | Diabetic Neuropathies; Drug-Related Side Effects and Adverse Reactions; Neutropenia | Details |
| Pegfilgrastim biosimilar (Amega Biotech) | Approved | Amega Biotech | Neutropenia | Details | ||||||
| Filgrastim biosimilar (Hangzhou Jiuyuan Gene Engineering) | Approved | Hangzhou Jiuyuan Gene Biomedical Co Ltd | 吉粒芬, Jilifen | Mainland China | Neutropenia | Hangzhou Jiuyuan Gene Biomedical Co Ltd | 1998-04-01 | Neutropenia | Details | |
| Filgrastim biosimilar (Probiomed) | Approved | Probiomed | Filatil | Mexico | Neutropenia | Probiomed | 2006-03-01 | Neutropenia | Details | |
| Filgrastim biosimilar (Emcure Pharmaceuticals) | Approved | Emcure Pharma | India | Neutropenia | Emcure Pharma | 2013-01-01 | Neutropenia | Details | ||
| Mecapegfilgrastim (Hengrui) | HHPG-19K | Approved | Jiangsu Hengrui Medicine Co Ltd | 艾多 | Mainland China | Neutropenia | Jiangsu Hengrui Medicine Co Ltd | 2018-05-08 | Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Chemotherapy-induced myelosuppression; Febrile Neutropenia; Neoplasms; Neutropenia; Thoracic Neoplasms | Details |
| Filgrastim biosimilar (Hospira) | PLD-108 | Approved | Hospira | Nivestim, Nivestym | EU | Hematopoietic stem cell transplantation (HSCT); Neutropenia; Neoplasms | Pfizer Europe Ma Eeig | 2010-06-07 | Febrile Neutropenia; Hematopoietic stem cell transplantation (HSCT); Neoplasms; Neutropenia | Details |
| Recombinant human granulocyte colony stimulating Factor (Beijing Four Rings Bio-Pharmaceutical) | Approved | Beijing Four Rings Bio-Pharmaceutical Co Ltd | 欣粒生, Xin Lisheng | Mainland China | Neutropenia | Beijing Four Rings Bio-Pharmaceutical Co Ltd | 2002-06-17 | Neutropenia | Details | |
| Pegfilgrastim biosimilar (Fresenius SE) | MSB-11455 | Approved | Merck Serono | Stimufend | EU | Chemotherapy-Induced Febrile Neutropenia; Neutropenia | Fresenius Kabi Deutschland Gmbh | 2022-03-28 | Chemotherapy-Induced Febrile Neutropenia; Febrile Neutropenia; Neutropenia | Details |
| Filgrastim biosimilar (Zuventus Healthcare) | Approved | Zuventus Healthcare | India | Neutropenia | Zuventus Healthcare | 2012-08-01 | Neutropenia | Details | ||
| Lenograstim biosimilar (Biosidus) | Approved | Biosidus | Lenobio, Leumostin, Lenograstim Biosidus | Neutropenia | Details | |||||
| Lipegfilgrastim | XM-22 | Approved | Teva | Lonquex | EU | Neutropenia | Teva Bv | 2013-07-25 | Neutropenia | Details |
| Albipagrastim alfa | rHSA-hG-CSF; MW-05; GW-003; 8MW-0511 | Approved | Mabwell (Shanghai) Bioscience Co Ltd | 迈粒生, MAILISHENG | Mainland China | Chemotherapy-Induced Febrile Neutropenia | Jiangsu T-Mab Bio-Pharmaceuticals Co Ltd | 2025-05-27 | Chemotherapy-Induced Febrile Neutropenia; Leukopenia; Neutropenia | Details |
| Filgrastim biosimilar (Neiss Labs) | Approved | Neiss Labs | Nisgras | India | Neutropenia | Neiss Labs | 2012-08-01 | Neutropenia | Details | |
| Filgrastim biosimilar (Fuji Pharmaceutical/Mochida/Gene Techno Science) | GBS-001; FSK-0808 | Approved | Fuji Pharmaceutical, Gene Techno Science, Mochda Pharmaceutical Co Ltd | Japan | Neutropenia | Fuji Pharmaceutical | 2012-11-21 | Neutropenia | Details | |
| Filgrastim biosimilar (Center of Molecular Immunology) | Approved | Center Of Molecular Immunology | ior-LeukoCIM | Cuba | Neutropenia | Center Of Molecular Immunology | 2016-01-14 | Neutropenia | Details | |
| Lenograstim | rG-CSF | Approved | Chugai Pharmaceutical Co Ltd | 格拉诺赛特, Neutrogin, Granocyte | Japan | Neutropenia | Chugai Pharmaceutical Co Ltd | 1991-10-04 | Hodgkin Disease; Lymphoma, Non-Hodgkin; Multiple Myeloma; Neutropenia | Details |
| Pegfilgrastim biosimilar (CinnaGen) | Approved | Cinnagen | PegaGen | Neutropenia | Details | |||||
| Pegfilgrastim biosimilar (Emcure Pharmaceuticals) | Approved | Emcure Pharma | Neutropenia | Details | ||||||
| Pegteograstim | MG-1107 | Approved | GC Biopharma Corp | Neulapeg | South Korea | Neutropenia | GC Biopharma Corp | 2014-01-01 | Febrile Neutropenia; Neutropenia; Solid tumours | Details |
| Filgrastim biosimilar (RAS Lifesciences) | Approved | Ras Lifesciences | India | Neutropenia | Ras Lifesciences | 2012-01-01 | Neutropenia | Details | ||
| Filgrastim biosimilar (Sudershan Biotech) | Approved | Sudershan Biotech Ltd | Neutropenia | Details | ||||||
| Filgrastim biosimilar (Shandong Quangang Pharmaceutical) | Approved | Shandong Quangang Pharmaceutical Co Ltd | 泉升, Quan Sheng | Mainland China | Neutropenia | Shandong Quangang Pharmaceutical Co Ltd | 2002-04-16 | Neutropenia | Details | |
| Pegfilgrastim biosimilar (Qilu Pharmaceuticals) | PEG-rhG-CSF (Qilu Pharmaceuticals) | Approved | Qilu Pharmaceutical Co Ltd | 新瑞白 | Mainland China | Neutropenia | Qilu Pharmaceutical Co Ltd | 2015-08-08 | Neutropenia | Details |
| Filgrastim biosimilar (RPG Life Sciences) | Approved | Rpg Life Sciences Ltd | Frastim | India | Neutropenia | Rpg Life Sciences Ltd | 2012-08-01 | Neutropenia | Details | |
| Pegfilgrastim biosimilar (Sandoz) | LAEP-2006 | Approved | Clariant Produkte (Schweiz) Ag | Zioxtenzo, Ziextenzo | EU | Neutropenia | Sandoz Gmbh | 2018-11-22 | Febrile Neutropenia; Neutropenia | Details |
| Telpegfilgrastim | YPEG-rhG-CSF | Approved | Xiamen Amoytop Biotech Co Ltd | 珮金, Pegneugen | Mainland China | Febrile Neutropenia | Xiamen Amoytop Biotech Co Ltd | 2023-06-30 | Febrile Neutropenia; Idiopathic short stature; Neutropenia; Pre-Eclampsia | Details |
| Pegfilgrastim biosimilar (CuraTeQ Biologics) | BP-14 | Approved | CuraTeQ Biologics Pvt Ltd | DYRUPEG | Neutropenia | Details | ||||
| Filgrastim biosimilar (Landsteiner) | Approved | Landsteiner Scientific | Biofilgran | Neutropenia | Details | |||||
| Filgrastim biosimilar (Sandoz) | EP-2006 | Approved | Sandoz | Zarxio, Zarzio | EU | Neutropenia; Chemotherapy-Induced Febrile Neutropenia | Hexal Ag | 2009-02-06 | Chemotherapy-Induced Febrile Neutropenia; Febrile Neutropenia; Neutropenia | Details |
| Pegfilgrastim biosimilar (Cinfa Biotech) | B-12019 | Approved | Cinfa Biotech Gmbh | Pelmeg | EU | Neutropenia | Mundipharma Corporation (Ireland) Ltd | 2018-11-20 | Neutropenia | Details |
| Filgrastim biosimilar (Pharmapark) | Approved | Pharmapark | Neutropenia | Pharmapark | 2008-01-01 | Neutropenia | Details | |||
| Filgrastim biosimilar(Curateq Biologics) | BP13(Curateq Biologics); BP-13(Curateq Biologics) | Approved | CuraTeQ Biologics Pvt Ltd | EU | Neutropenia | CuraTeQ Biologics Pvt Ltd | 2025-02-12 | Febrile Neutropenia; Neutropenia | Details | |
| Filgrastim biosimilar (NCPC GeneTech Biotechnology Development) | Approved | North China Pharmaceutical Company Ltd | GeSysin | Mainland China | Neutropenia | North China Pharmaceutical Company Ltd | 1999-01-01 | Neutropenia | Details | |
| Pegfilgrastim biosimilar(Nora Pharma) | Approved | Nora Pharma Inc | NIOPEG | Canada | Febrile Neutropenia | Nora Pharma Inc | 2024-04-19 | Febrile Neutropenia | Details | |
| Filgrastim biosimilar (Chengdu Institute of Biological Products) | Approved | Chengdu Institute Of Biological Products Co Ltd | 保力津, Baolijin | Mainland China | Neutropenia | Chengdu Institute Of Biological Products Co Ltd | 2001-01-01 | Neutropenia | Details | |
| Pegfilgrastim biosimilar (mochida) | GBS-010; MD110 | Approved | Mochda Pharmaceutical Co Ltd | Japan | Febrile Neutropenia | Mochda Pharmaceutical Co Ltd | 2023-09-25 | Chemotherapy-Induced Febrile Neutropenia; Febrile Neutropenia | Details | |
| Recombinant Human Granulocyte/Macrophage Colony-stimulating Factor for Injection (Foshan Hanyu) | Approved | Foshan Hanyu Biopharmaceutical Co Ltd | 格宁 | Mainland China | Neutropenia | Foshan Hanyu Biopharmaceutical Co Ltd | 1998-01-01 | Neutropenia | Details | |
| Recombinant Human Granulocyte/Macrophage Colony-stimulating Factor for Injection (Beijing Beiyi Union) | Approved | Beijing Beiyi Union Pharmaceutical Co Ltd | 健白 | Mainland China | Neutropenia | Beijing Beiyi Union Pharmaceutical Co Ltd | 2002-05-08 | Neutropenia | Details | |
| Recombinant human granulocyte macrophage colony stimulating factor (Kyowa Hakko Kirin) | Approved | Ise Plant, Nipro Pharma Corp, Kyowa Kirin China Pharmaceutical Co Ltd, Kyowa Kirin Co Ltd | Details | |||||||
| Pegylated recombinant human granulocyte colony stimulating factor (Hangzhou Jiuyuan Gene) | JY06 | Approved | Hangzhou Jiuyuan Gene Biomedical Co Ltd | 吉新芬 | Mainland China | Neutropenia | Hangzhou Jiuyuan Gene Biomedical Co Ltd | 2025-01-14 | Febrile Neutropenia; Neoplasms; Neutropenia | Details |
| Pegfilgrastim biosimilar(Shandong New Time Pharmaceutical ) | Approved | Shandong New Time Pharmaceutical Co Ltd | Details | |||||||
| Pegfilgrastim biosimilar (Biocon/Mylan) | MYL-1401H | Approved | Biocon Ltd | Fulphila | United States | Febrile Neutropenia | Mylan Gmbh | 2018-06-04 | Chemotherapy-Induced Febrile Neutropenia; Febrile Neutropenia; Neutropenia | Details |
| Pegfilgrastim biosimilar (Dong-A ST) | DA-3031 | Approved | Dong-A Pharmaceutical Co Ltd | Dulastin | South Korea | Neutropenia | Dong-A Pharmaceutical Co Ltd | 2014-01-01 | Neutropenia | Details |
| Filgrastim biosimilar (CIGB/Heber Biotec) | Approved | Center For Genetic Engineering And Biotechnology, Heber Biotec | Hebervital | Neutropenia | null | 2009-01-01 | Neutropenia | Details | ||
| Filgrastim biosimilar (Qilu Pharmaceutical) | Approved | Qilu Pharmaceutical Co Ltd | 瑞白 | Mainland China | Neutropenia | Qilu Pharmaceutical Co Ltd | 1999-01-01 | Neutropenia | Details | |
| Molgramostim biosimilar (RAS Lifesciences) | Approved | Biomerieux | India | Neutropenia | Biomerieux | 2012-10-01 | Neutropenia | Details | ||
| Pegylated recombinant human granulocyte colony stimulating factor (CSPC Pharma) | Approved | CSPC Pharmaceutical Group Ltd | 津优力, Pegleukim | Mainland China | Neutropenia | Cspc Baike (Shandong) Biopharmaceutical Co Ltd | 2011-10-21 | Neutropenia | Details | |
| Filgrastim biosimilar (Dr Reddy's Laboratories) | Approved | Dr.Reddy's Laboratories Ltd | Grafeel | India | Neutropenia | Dr.Reddy's Laboratories Ltd | 2001-01-01 | Neutropenia | Details | |
| Pegfilgrastim biosimilar (Adello Biologics) | TPI-120 | Approved | Adello Biologics Llc | FYLNETRA, PexegraTM, Releuko | United States | Neutropenia; Febrile Neutropenia; Chemotherapy-Induced Febrile Neutropenia | Kashiv BioSciences LLC | 2022-02-25 | Chemotherapy-Induced Febrile Neutropenia; Febrile Neutropenia; Neutropenia | Details |
| Pegfilgrastim biosimilar (Lupin) | Approved | Lupin Ltd | Armlupeg, Lupifil-P, ARMLUPEG | India | Neutropenia | Lupin Ltd | 2016-01-01 | Febrile Neutropenia; Neutropenia | Details | |
| Filgrastim biosimilar (Elea) | Approved | Elea | Neutropenia | Details | ||||||
| Pegfilgrastim biosimilar (Dr Reddy's Laboratories) | DRL_PG | Approved | Dr.Reddy's Laboratories Ltd | Peg-grafeel | India | Neutropenia | Dr.Reddy's Laboratories Ltd | 2011-01-01 | Neutropenia | Details |